Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis.
Reumatol Clin (Engl Ed)
; 19(10): 533-548, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-38008602
Key words
Artritis reumatoide; Biologics; Biológicos; Cáncer de piel no melanoma; Cáncer hematológico; Hematologic cancer; Hepatitis B; Herpes zoster; Human papillomavirus; Infecciones; Infections; Inhibidores de las JAK; JAK inhibitors; Non-melanoma skin cancer; Rheumatoid arthritis; Virus del papiloma humano
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Rheumatology
/
Janus Kinase Inhibitors
Type of study:
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Reumatol Clin (Engl Ed)
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: